The WSCMC has found the following factors that influence the stem cell therapy effect:
-
The unchanged pathological internal environment
-
The lack of precise positioning of the stem cells activated or implanted
-
The impassable scar tissues that are hard for the neural stem cell cone to pass through
-
The technical difficulties in targeted differentiation of the stem cells inside the body and in the cross-TM trophoblast transformation of the stem cells
-
The nonfunctioning of the surviving stem cells
Any of these factors can and will contribute to the poor, or non-effectiveness of the stem cell therapy.
To overcome the above-mentioned difficulties and maximize effectiveness the WSCMC provides an innovative approach that combines the activation of autologous neural stem cells with exogenous stem cell transplantation.
The approaches to activate autologous stem cells involves:
The approach to make the exogenous stem cells function includes:
-
having the implanted stem cells activate the autologous stem cells and make them form neural networks with the implanted stem cells
-
making the autologous stem cells functional through chemical and physical signal regulation and thus inducing the implanted stem cells to differentiate into the functional cells.
This innovative approach has achieved:
-
An improved the patient's internal environment
-
Has allowed the accurate positioning of the cell receptor and gene targeting to occur
-
Has softened the scar tissues to allow the neural stem cell cones to pass through and to induce the directional stem cell differentiation inside the body, or to make the stem cells cross the embryonic layer for transformation. By chemical and physical regulations, the survived stem cells are able to take their functions
The entire WSCMC program is 5 to 7 weeks long dependent upon each individual patients needs and medical condition. When a patients future is at stake and long term medical results are desired there is no room for short cuts.
